While clinical trials linked Wegovy to triple the risk of hair loss when compared to those who took a placebo, no such side effects are listed in reference to Ozempic, which is typically given at a much lower dose when used for treatment of diabetes
Glucagon and GLP-1 Receptor Co-agonists Glucagon is a hormone that raises blood sugar levels, while GLP-1 lowers them
GLP-1 receptor agonists mimic this natural hormone to: Slow down gastric emptying Increase insulin secretion Decrease glucagon release Reduce appetite and food intake These effects lead to lower blood sugar levels and gradual, sustained weight loss
Hu Y, Zheng S-L, Ye X-L, et al
Caputi, B
David Hunter, MD, an associate professor of neurology at UTHealth Houston, not involved in this review, spoke with Medical News Today about its findings